Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients

SIMPLE SUMMARY: BRAF inhibitors (BRAFi) are standard of care for BRAF-mutated metastatic melanoma (MM). One of the most common side effects is arthralgia, for which a high incidence has been described, but whose clinical presentation and management have not yet been characterized. The aim of this re...

Descripción completa

Detalles Bibliográficos
Autores principales: Salzmann, Martin, Benesova, Karolina, Buder-Bakhaya, Kristina, Papamichail, Dimitrios, Dimitrakopoulou-Strauss, Antonia, Lorenz, Hanns-Martin, Enk, Alexander H., Hassel, Jessica C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602871/
https://www.ncbi.nlm.nih.gov/pubmed/33081201
http://dx.doi.org/10.3390/cancers12103004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602871/
https://www.ncbi.nlm.nih.gov/pubmed/33081201
http://dx.doi.org/10.3390/cancers12103004

Ejemplares similares